Walgreens, kaléo expand Auvi-Q dosage availability
Walgreens and pharmaceutical company kaléo are expanding their collaboration to bring a new dosage strength of the Auvi-Q epinephrine auto-injector to Walgreens patients.
The Auvi-q 0.1 mg, intended for infants and toddlers weighing between 16.5 and 33 lbs., now is available at Walgreens pharmacies, making Walgreens the first national retail pharmacy to offer the full Auvi-Q lineup of dosage strengths — 0.1 mg, 0.15 mg and 0.3 mg. The epinephrine auto-injectors are available to eligible patients with commercial insurance for no cost, even those with high-deductible plans, and patients without commercial insurance or prescription drug coverage may be eligible for support through the kaléo Cares Patient Assistance Program.
“With the addition of an AUVI-q auto-injector for infants and toddlers at Walgreens pharmacies nationwide, we can help ensure families and children facing life-threatening allergies have convenient and affordable access to the medicines they need,” said Rina Shah, PharmD, group vice president of specialty and retail pharmacy at Walgreens. “Expanding our agreement with kaléo is one more way that Walgreens is helping lower costs for patients, increasing accessibility to care and creating a seamless experience for our customers and patients.”
The companies said their collaboration is meant to broaden access to epinephrine auto-injectors for those who need it, particularly amid supply issues related to other brands. Auvi-Q includes a voice instruction system to guide users through the injection process, as well as an auto-retracting needle.
“With approximately one in 13 children in the U.S. living with life-threatening food allergies2, it is critically important that parents and caregivers be able to access an epinephrine auto-injector,” said Phil Rackliffe, general manager of allergy and pediatrics at kaléo. “Families can get AUVI-Q 0.3 mg, 0.15 mg, and now, 0.1 mg, with a prescription, on-site at Walgreens locations nationwide.”
No comments found